
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Capped nascent RNA sequencing reveals novel therapy-responsive enhancers in prostate cancer - Li Yao</title>
    <link type="text/css" href="/assets/css/796.73088b498cbaa1fd5906.css" rel="stylesheet" />
<link type="text/css" href="/assets/css/212.5830dd80db2577f64f25.css" rel="stylesheet" />
    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-KGJ9HPC');</script>
    <!-- End Google Tag Manager -->
</head>
<body>
<!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KGJ9HPC"
    height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <!-- End Google Tag Manager (noscript) -->
<div class="container-fluid nav-container">
    <div class="container">
        <nav class="navbar navbar-expand-lg bg-transparent top-nav">
            <div class="container-fluid">
                <a class="navbar-brand" href="#">Li Yao</a>
                <button class="navbar-toggler" type="button" data-bs-toggle="collapse"
                        data-bs-target="#navbarSupportedContent" aria-controls="navbarSupportedContent"
                        aria-expanded="false" aria-label="Toggle navigation">
                    <span class="navbar-toggler-icon"></span>
                </button>
                <div class="collapse navbar-collapse" id="navbarSupportedContent">
                    <ul class="navbar-nav me-auto mb-2 mb-lg-0">
                        <li class="nav-item">
                            <a class="nav-link " aria-current="page" href="/">Home</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link active" href="/publications/">Publications</a>
                        </li>
                        <li class="nav-item">
                            <a class="nav-link " href="/software/">Software</a>
                        </li>
<!--                        <li class="nav-item">-->
<!--                            <a class="nav-link " href="#">Posts</a>-->
<!--                        </li>-->
                    </ul>
                </div>
            </div>
        </nav>
    </div>
</div>

<div class="header-container content-header" id="">
    <div class="visually-hidden">
        <h1 class="display-1">Capped nascent RNA sequencing reveals novel therapy-responsive enhancers in prostate cancer </h1>
        <p class="lead"><p>AbstractMounting evidence suggests that enhancer RNA (eRNA) transcription start sites (TSSs) provide higher sensitivity and specificity for enhancer identification than histone modifications and chromatin accessibility. The extent to which changes in eRNA transcription correspond to changes in enhancer activity, however, remains unclear. Here, we used precision run-on and capped RNA sequencing (PRO-cap) to assess changes in enhancer activity in response to treatment with the androgen receptor signaling inhibitor, enzalutamide (ENZ). We identified 6,189 high-confidence candidate enhancers in the human prostate cancer cell line, LNCaP; 853 of which demonstrated significant changes in activity in response to drug treatment. Notably, we found that 67% and 54% of drug-responsive enhancers did not show similar changes in activity in previous studies that utilized ChIP-seq and ATAC-seq, respectively. Strikingly, 79% of regions with increased eRNA transcription showed no other biochemical alterations, implying that PRO-cap can capture a set of precise changes in enhancer activity that classical approaches lack the sensitivity to detect. We performed in vivo functional validations of candidate enhancers and found that CRISPRi targeting of PRO-cap-specific drug-responsive enhancers impaired ENZ regulation of downstream target genes, suggesting that changes in eRNA TSSs mark true biological changes in enhancer activity with high sensitivity. Our study highlights the utility of using PRO-cap as a complementary approach to canonical biochemical methods for detecting precise changes in enhancer activity and, in particular, for better understanding disease progression and responses to treatment.</p></p>
    </div>
</div>
<div class="container">
    <div class="row">
        <div class="col-lg-10 default-content-container card" data-bs-spy="scroll" data-bs-target="#tocSidebar">
            <div class="card-body">
                <h1>Capped nascent RNA sequencing reveals novel therapy-responsive enhancers in prostate cancer</h1>
                <small>Release time:  - Updated: May 13, 2025, 12:25 a.m.</small>
                <hr class="d-none d-md-block my-2">
                
                <h2 id="toc_abstract">Abstract</h2><p>AbstractMounting evidence suggests that enhancer RNA (eRNA) transcription start sites (TSSs) provide higher sensitivity and specificity for enhancer identification than histone modifications and chromatin accessibility. The extent to which changes in eRNA transcription correspond to changes in enhancer activity, however, remains unclear. Here, we used precision run-on and capped RNA sequencing (PRO-cap) to assess changes in enhancer activity in response to treatment with the androgen receptor signaling inhibitor, enzalutamide (ENZ). We identified 6,189 high-confidence candidate enhancers in the human prostate cancer cell line, LNCaP; 853 of which demonstrated significant changes in activity in response to drug treatment. Notably, we found that 67% and 54% of drug-responsive enhancers did not show similar changes in activity in previous studies that utilized ChIP-seq and ATAC-seq, respectively. Strikingly, 79% of regions with increased eRNA transcription showed no other biochemical alterations, implying that PRO-cap can capture a set of precise changes in enhancer activity that classical approaches lack the sensitivity to detect. We performed in vivo functional validations of candidate enhancers and found that CRISPRi targeting of PRO-cap-specific drug-responsive enhancers impaired ENZ regulation of downstream target genes, suggesting that changes in eRNA TSSs mark true biological changes in enhancer activity with high sensitivity. Our study highlights the utility of using PRO-cap as a complementary approach to canonical biochemical methods for detecting precise changes in enhancer activity and, in particular, for better understanding disease progression and responses to treatment.</p>
            </div>
        </div>
        <nav id="tocSidebar" class="col-lg-2 d-none d-lg-block mt-3">
            <div class="position-sticky" style="top: 1rem;">
                <strong class="d-none d-md-block h6 my-2 ms-3">On this page</strong>
                <hr class="d-none d-md-block my-2 ms-3">
                <div class="list-group" id="tocList">
                
<ul class="nav nav-pill nav-bar flex-column">
  
    <li class="nav-item">
      
        <!-- Regular link -->
        <a class="nav-link p-1 ps-2 ms-30" href="#toc_abstract">Abstract</a>
      
    </li>
  
</ul>

                </div>
            </div>
        </nav>
    </div>
</div>

<div class="container-fluid foot-container my-3">
    <div class="container pt-3 text-center">
        <ul class="list-inline">
            <li class="list-inline-item">My pages at other platforms:</li>
            <li class="list-inline-item">
                <a href="https://orcid.org/0000-0003-2827-8824" rel="external nofollow" class="icon-link icon-link-hover icon-link-orcid link-underline link-underline-opacity-0" target="_blank"><i class="bi fa-brands fa-orcid"></i> ORCID</a>
            </li>
            <li class="list-inline-item">
                <a href="https://scholar.google.com/citations?hl=en&user=CBFQNG0AAAAJ" rel="external nofollow" class="icon-link icon-link-hover icon-link-gs link-underline link-underline-opacity-0" target="_blank"><i class="bi fa-brands fa-google-scholar"></i> Google Scholar</a>
            </li>
            <li class="list-inline-item">
                <a href="https://github.com/liyao001" rel="external nofollow" class="icon-link icon-link-hover icon-link-gh link-underline link-underline-opacity-0" target="_blank"><i class="bi fa-brands fa-github"></i> GitHub</a>
            </li>
        </ul>
        &copy; Li Yao 2019-2025.
    </div>
</div>
<script src="/assets/vendors/js/three.min.js"></script>


<script type="text/javascript" src="/assets/js/runtime.e2987ff7.js" charset="UTF-8"></script>
<script type="text/javascript" src="/assets/js/577.8f5be76e.js" charset="UTF-8"></script>
<script type="text/javascript" src="/assets/js/contents.67c34ea9.js" charset="UTF-8"></script>

</body>
</html>